Daunorubicin

In the US, Daunorubicin (daunorubicin systemic) is a member of the drug class antibiotics/antineoplastics and is used to treat Acute Lymphocytic Leukemia, Acute Myeloid Leukemia and Acute Nonlymphocytic Leukemia.

US matches:

• Daunorubicin
• Daunorubicin liposomal
• Daunorubicin Intravenous
• Daunorubicin citrate liposome Intravenous
• Daunorubicin citrate
• Daunorubicin hydrochloride
• Daunorubicin Citrate Liposomal

UK matches:

• DAUNORUBICIN (Leaflet)

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

L01DB02

CAS registry number (Chemical Abstracts Service)

0020830-81-3

Chemical Formula

C27-H29-N-O10

Molecular Weight

527

Therapeutic Category

Antineoplastic agent: Cytotoxic antibacterial from the group of anthracyclines

Chemical Names

(1S,3S)-3-Acetyl-1,2,3,4,6,11-hexahydro-3,5,12-trihydroxy-10-methyloxy-6,11-dioxo-naphtacen-1-yl 3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranoside (BAN)

(1S,3S)-3-Acetyl-1,2,3,4,6,11-hexahydro-3,5,12-trihydroxy-10-methyloxy-6,11-dioxo-naphtacenyl 3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranoside (WHO)

(1S,3S)-3-Acetyl-3,5,12-trihydroxy-10-methyloxy-6,11-dioxo--1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-tridesoxy-α-L-lyxo-hexopyranoside (IUPAC)

Foreign Names

• Daunorubicinum (Latin)
• Daunorubicin (German)
• Daunorubicine (French)
• Daunorubicina (Spanish)

Generic Names

• Daunorubicin (OS: BAN)
• Daunorubicina (OS: DCIT)
• Daunorubicine (OS: DCF)
• Daunomycin (IS)
• DNR (IS)
• FI 6339 (IS)
• NSC 82151 (IS)
• RP 13057 (IS)
• Rubidomycin (IS)
• Daunorubicin, liposomal (IS)
• Daunorubicin Hydrochloride (OS: USAN, BANM)
• NDC 0082-4155 (IS)
• Daunorubicin hydrochloride (PH: Ph. Eur. 7)
• Daunorubicin Hydrochloride (PH: BP 2011, JP XV, USP 34)
• Daunorubicine (chlorhydrate de) (PH: Ph. Eur. 7)
• Daunorubicinhydrochlorid (PH: Ph. Eur. 7)
• Daunorubicini hydrochloridum (PH: Ph. Eur. 7)

Brand Names

• Daunoblastina
  Pfizer, China; Pfizer, Peru; Pfizer, Singapore; Pharmacia Upjohn, Oman
• Daunorrubicina
  GP-Pharm, Peru; World Pharma, Peru
• Daunorubicina GP Pharm
  GP Pharm, Argentina
• Norubin (Daunorubicin and Mannitol)
  Cadila, India
• DaunoXome
  Diatos, Denmark; Galen, United Kingdom; Galen, United States
• Cerubidin Orifarm
  Sanofi-Aventis, Denmark
• Cerubidin
  Sanofi-Aventis, Ireland; Sanofi-Aventis, Norway
• Cerubidine
  Bedford, United States; Sanofi-Aventis, Belgium; Sanofi-Aventis, Netherlands; Sicor, United States
• Cérubidine
  Sanofi-Aventis, France
• Daunoblastin
  Pfizer, Austria; Pfizer, Bosnia & Herzegowina; Pfizer, Germany; Pfizer, South Africa
• Daunoblastina
  Actavis, Serbia; IFET, Greece; Pfizer, Bahrain; Pfizer, Brazil; Pfizer, Estonia; Pfizer, Spain; Pfizer, Hong Kong; Pfizer, Croatia (Hrvatska); Pfizer, Hungary; Pfizer, Taiwan; Pfizer, Venezuela; Pfizer, Vietnam; Pfizer Italia, Italy; Unifarm, Romania
• Daunocin
  Korea United Pharm, Georgia; Meizler, Brazil
• Daunogobbi (Daunorubicin and Mannitol)
  Gobbi, Argentina
• Daunomicina
  Deva, Turkey
• Daunomycin
  Meiji Seika Kaisha, Japan
• Daunorrubicina Pfizer
  Pfizer, Chile
• Daunorubicin - Hisun
  Hisun, China
• Daunorubicin - Main Luck
  Main Luck Pharmaceutical, China
• Daunorubicin hydrochloride
  Bedford, United States; Teva, United States
• Daunorubicin
  Zentiva, United Kingdom
• Daunorubicina
  Pfizer, Ecuador
• DaunoXome
  Gilead, Ireland; Nexstar, Greece; Novex, France
• DBL Daunorubicin Hydrochloride
  Hospira, New Zealand
• Maxidauno
  Varifarma, Argentina

International Drug Name Search

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.